|
US2015320767A1
|
|
Progesterone treatment for improving sleep quality
|
|
AU2014226192A1
|
|
Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
|
|
ZA201208077B
|
|
Low-oil pharmaceutical emulsion compositions comprising progestogen
|
|
TN2012000505A1
|
|
Low-oil pharmaceutical emulsion compositions comprising progestogen
|
|
TW201138782A
|
|
Low-oil pharmaceutical emulsion compositions comprising progestogen
|
|
EP2493508A2
|
|
Transdermal pharmaceutical compositions comprising active agents
|
|
HUE049799T2
|
|
Transdermal pharmaceutical compositions comprising a serm
|
|
AU2007238341A1
|
|
Treatment of menopause-associated symptoms
|
|
AU2005227072A1
|
|
Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
|
|
AU2004246812A1
|
|
Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
|
|
AU2003303033A1
|
|
Treatment of mastalgia with 4-hydroxy tamoxifen
|
|
EP1941871A1
|
|
Formulations for prevention and treatment of breast cancer with 4-hydroxy tamoxifen
|
